• Vitamin D Testing Market Share, Size, Business Growth, New Trends, Technological Innovations, Opportunities and Demand Forecast by 2033

    The Vitamin D Testing Market is predicted to be worth US$ 917.55 million in 2023 and rise to US$ 1,999.35 million by 2033. Initially, the global market was expanding at a CAGR of 6% from 2018 to 2022.

    Technology advancement has greatly improved the precision and usefulness of vitamin D testing kits. With just a small blood sample, these kits are readily available and can accurately detect the body's vitamin D levels.  The use of vitamin D testing kits has increased as a result of the emergence of immunoassay-based methods, which can distinguish between vitamin D2 and D3 forms.

    Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16906

    Testing vitamin levels at home is now simple owing to the technology. With the availability of new technology, it is now possible to create fast vitamin D testing that is incredibly reliable and simple to use at home. The combination of increased knowledge of vitamin D importance and the availability of accurate rapid vitamin D testing is largely responsible for the favorable market prediction.

    Both government and business sector efforts to raise awareness of vitamin D deficiency are boosting public understanding of vitamin D. Its nutritional benefits and use of vitamin D testing procedures are further driving the market. For instance, in order to raise women's awareness of bone health, Horlicks Women's Plus and Apollo Clinic joined in January 2022.

    Key Takeaways

    In 2018, China expanded at a market value of US$ 38.4 billion in the vitamin D testing market. The market is expected to reach US$ 74.9 million in 2023.
    The vitamin D testing market was significantly expanding, with a size of US$ 848.8 billion in 2022.
    The market is anticipated to reach a valuation of US$ 1,159.08 million by 2026, as a result of emerging cloud-based platforms.
    Due to the market's excellent potential and utilization of smartphones in testing, analysts expect it is likely to rise 1.08 times between 2022 and 2023.
    As demand for preventive healthcare solutions rises, the United Kingdom market is expected to develop at a prodigious CAGR by 2033.
    Based on product type, the 25-hydroxy vitamin D test dominated the market in 2022 and continued to lead the market during the forecast period.
    Based on indications, osteoporosis led the market in 2022 and continues to lead the market during the forecast period.
    The LC-MS segment dominated the market in 2022 and is likely to hold the top spot throughout the projected period.
    Based on patient category, adult patients led the market in 2022 and continues to lead during the forecast period

    Critical Approaches Increasing Top Players' Wealth

    Due to a few dominant competitors controlling the bulk of market shares, the vitamin D testing industry is consolidated in nature. One of the primary reasons for market dominance is the development of cutting-edge modern technologies that give patients precise outcomes.

    Recent Developments

    In order to increase the presence of its brand, Thermo Fisher Scientific Inc. made declared in March 2020. The Cascadion SM Clinical Analyzer for the Cascadion SM 25-hydroxy vitamin D assay is now offered in the United States.
    In January 2022, F. Hoffmann-La Roche Ltd. released Cobas Infinity Edge. It is a cloud-based platform for integrating and managing point-of-care data that can be used in clinical settings anywhere in the world.

    Key Players

    Abbott
    F. Hoffmann-La Roche Ltd
    BIOMÉRIEUX
    Thermo Fisher Scientific Inc.
    Danaher
    Siemens Healthineers AG
    DiaSorin S.p.A.
    Beckman Coulter, Inc. (BD)
    Tosoh Bioscience, Inc.
    Quest Diagnostics Incorporated.

    Key Segments

    Vitamin D Testing By Product:

    25-Hydroxy Vitamin D Testing
    1,25-Dihydroxy Vitamin D Testing

    Vitamin D Testing by Indication:

    Vitamin D Testing for Osteoporosis
    Vitamin D Testing for Rickets
    Vitamin D Testing for Thyroid Disorders
    Vitamin D Testing for Vitamin D Deficiency
    Others

    Vitamin D Testing by Technology:

    Radioimmunoassay
    ELISA
    HPLC
    LC-MS
    Others

    Vitamin D Testing by Patient:

    Vitamin D Testing in Adult
    Vitamin D Testing in Pediatric

    Vitamin D Testing by Test Location:

    Vitamin D Testing at Point-of-Care
    Others

    Vitamin D Testing by End-use:

    Vitamin D Testing for Hospitals
    Vitamin D Testing for Diagnostic Laboratories
    Vitamin D Testing for Homecare
    Others
    Vitamin D Testing Market Share, Size, Business Growth, New Trends, Technological Innovations, Opportunities and Demand Forecast by 2033 The Vitamin D Testing Market is predicted to be worth US$ 917.55 million in 2023 and rise to US$ 1,999.35 million by 2033. Initially, the global market was expanding at a CAGR of 6% from 2018 to 2022. Technology advancement has greatly improved the precision and usefulness of vitamin D testing kits. With just a small blood sample, these kits are readily available and can accurately detect the body's vitamin D levels.  The use of vitamin D testing kits has increased as a result of the emergence of immunoassay-based methods, which can distinguish between vitamin D2 and D3 forms. Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16906 Testing vitamin levels at home is now simple owing to the technology. With the availability of new technology, it is now possible to create fast vitamin D testing that is incredibly reliable and simple to use at home. The combination of increased knowledge of vitamin D importance and the availability of accurate rapid vitamin D testing is largely responsible for the favorable market prediction. Both government and business sector efforts to raise awareness of vitamin D deficiency are boosting public understanding of vitamin D. Its nutritional benefits and use of vitamin D testing procedures are further driving the market. For instance, in order to raise women's awareness of bone health, Horlicks Women's Plus and Apollo Clinic joined in January 2022. Key Takeaways In 2018, China expanded at a market value of US$ 38.4 billion in the vitamin D testing market. The market is expected to reach US$ 74.9 million in 2023. The vitamin D testing market was significantly expanding, with a size of US$ 848.8 billion in 2022. The market is anticipated to reach a valuation of US$ 1,159.08 million by 2026, as a result of emerging cloud-based platforms. Due to the market's excellent potential and utilization of smartphones in testing, analysts expect it is likely to rise 1.08 times between 2022 and 2023. As demand for preventive healthcare solutions rises, the United Kingdom market is expected to develop at a prodigious CAGR by 2033. Based on product type, the 25-hydroxy vitamin D test dominated the market in 2022 and continued to lead the market during the forecast period. Based on indications, osteoporosis led the market in 2022 and continues to lead the market during the forecast period. The LC-MS segment dominated the market in 2022 and is likely to hold the top spot throughout the projected period. Based on patient category, adult patients led the market in 2022 and continues to lead during the forecast period Critical Approaches Increasing Top Players' Wealth Due to a few dominant competitors controlling the bulk of market shares, the vitamin D testing industry is consolidated in nature. One of the primary reasons for market dominance is the development of cutting-edge modern technologies that give patients precise outcomes. Recent Developments In order to increase the presence of its brand, Thermo Fisher Scientific Inc. made declared in March 2020. The Cascadion SM Clinical Analyzer for the Cascadion SM 25-hydroxy vitamin D assay is now offered in the United States. In January 2022, F. Hoffmann-La Roche Ltd. released Cobas Infinity Edge. It is a cloud-based platform for integrating and managing point-of-care data that can be used in clinical settings anywhere in the world. Key Players Abbott F. Hoffmann-La Roche Ltd BIOMÉRIEUX Thermo Fisher Scientific Inc. Danaher Siemens Healthineers AG DiaSorin S.p.A. Beckman Coulter, Inc. (BD) Tosoh Bioscience, Inc. Quest Diagnostics Incorporated. Key Segments Vitamin D Testing By Product: 25-Hydroxy Vitamin D Testing 1,25-Dihydroxy Vitamin D Testing Vitamin D Testing by Indication: Vitamin D Testing for Osteoporosis Vitamin D Testing for Rickets Vitamin D Testing for Thyroid Disorders Vitamin D Testing for Vitamin D Deficiency Others Vitamin D Testing by Technology: Radioimmunoassay ELISA HPLC LC-MS Others Vitamin D Testing by Patient: Vitamin D Testing in Adult Vitamin D Testing in Pediatric Vitamin D Testing by Test Location: Vitamin D Testing at Point-of-Care Others Vitamin D Testing by End-use: Vitamin D Testing for Hospitals Vitamin D Testing for Diagnostic Laboratories Vitamin D Testing for Homecare Others
    0 Comments 0 Shares 1823 Views
Sponsored
Sponsored